MMP9 and cancer: The pre‐invaded GM6001‐treated monocytes formed cell–cell contact‐based junction in initial phase of invasion within the matrix (<150 μm), and then worked as a barrier for subsequent cancer cells to invade and further hampering cancer cell extravasation in addition to impaired MMP9 function.